SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

Clinical trial NCT00091130 · COMPLETED

Trial details

NCT number: NCT00091130
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atypical Squamous Cells of Undetermined Significance Cervical Cancer High-grade Squamous Intraepithelial Lesion Low-grade Squamous Intraepithelial Lesion

Start date: 2004-09-01
Primary completion: 2007-06-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.